pGMEH-P38-mRFP Citations (3)

Originally described in: Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase.
Kim JH, Wei JR, Wallach JB, Robbins RS, Rubin EJ, Schnappinger D Nucleic Acids Res. 2011 Mar;39(6):2210-20. doi: 10.1093/nar/gkq1149 PubMed Journal

---

Articles Citing pGMEH-P38-mRFP

Articles
Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria. Moreira W, Ngan GJ, Low JL, Poulsen A, Chia BC, Ang MJ, Yap A, Fulwood J, Lakshmanan U, Lim J, Khoo AY, Flotow H, Hill J, Raju RM, Rubin EJ, Dick T. MBio. 2015 May 5;6(3):e00253-15. doi: 10.1128/mBio.00253-15. PubMed
Boromycin Kills Mycobacterial Persisters without Detectable Resistance. Moreira W, Aziz DB, Dick T. Front Microbiol. 2016 Feb 22;7:199. doi: 10.3389/fmicb.2016.00199. eCollection 2016. PubMed
Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption. Shetty A, Xu Z, Lakshmanan U, Hill J, Choong ML, Chng SS, Yamada Y, Poulsen A, Dick T, Gengenbacher M. Front Microbiol. 2018 Dec 4;9:2960. doi: 10.3389/fmicb.2018.02960. eCollection 2018. PubMed

If you have published an article using this material, please email us at to have your article added to this page.